Cite

    Van Broekhoven, A., Mohammadnia, N., Silvis, M. J. M., Los, J., Fiolet, A. T. L., Opstal, T. S. J., Mosterd, A., Eikelboom, J. W., Nidorf, S. M., Bax, W. A., Tijssen, J. G. P., De Kleijn, D. P. V., Thompson, P. L., El Messaoudi, S., & Cornel, J. H. (n.d.). end-of-trial inflammatory biomarkers, lipid levels, creatine kinase and markers of renal and liver function in the LoDoCo2 trial. European heart journal, 43, . http://access.bl.uk/ark:/81055/vdc_100168330774.0x00004b